FI971275A0 - Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset - Google Patents

Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset

Info

Publication number: FI971275A0
Authority: FI; Finland
Prior art keywords: inactivated; recombinant adenovirus; deficient recombinant; iva2 gene; gene
Prior art date: 1994-09-27

Application number

FI971275A

Other languages

English (en)

Swedish (sv)

Other versions

FI971275A7 (fi

FI971275L (fi

Inventor

Cecile Orsini

Michel Perricaudet

Emmanuelle Vigne

Patrice Yeh

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-27

Filing date

1995-09-22

Publication date

1997-03-26

1995-09-22 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1997-03-26 Publication of FI971275A7 publication Critical patent/FI971275A7/fi

1997-03-26 Publication of FI971275L publication Critical patent/FI971275L/fi

1997-03-26 Publication of FI971275A0 publication Critical patent/FI971275A0/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/01—DNA viruses
- C07K14/075—Adenoviridae
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10361—Methods of inactivation or attenuation
- C12N2710/10362—Methods of inactivation or attenuation by genetic engineering
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/108—Plasmid DNA episomal vectors

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
General Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Molecular Biology (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Plant Pathology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
Immunology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

FI971275A 1994-09-27 1995-09-22 Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset FI971275A0 (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9411511A FR2724945B1 (fr)	1994-09-27	1994-09-27	Vecteurs viraux et utilisation en therapie genique
PCT/FR1995/001228 WO1996010088A1 (fr)	1994-09-27	1995-09-22	ADENOVIRUS RECOMBINANTS DEFECTIFS AVEC UN GENE IVa2 INACTIVE

Publications (3)

Publication Number	Publication Date
FI971275A7 FI971275A7 (fi)	1997-03-26
FI971275L FI971275L (fi)	1997-03-26
FI971275A0 true FI971275A0 (fi)	1997-03-26

Family

ID=9467310

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI971275A FI971275A0 (fi)	1994-09-27	1995-09-22	Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset

Country Status (18)

Country	Link
US (1)	US6200798B1 (fi)
EP (1)	EP0783585B1 (fi)
JP (1)	JPH10506018A (fi)
KR (1)	KR100484441B1 (fi)
AT (1)	ATE331801T1 (fi)
AU (1)	AU712304B2 (fi)
CA (1)	CA2197904A1 (fi)
DE (1)	DE69535093T2 (fi)
DK (1)	DK0783585T3 (fi)
ES (1)	ES2268695T3 (fi)
FI (1)	FI971275A0 (fi)
FR (1)	FR2724945B1 (fi)
IL (1)	IL115432A (fi)
MX (1)	MX9701766A (fi)
NO (1)	NO319055B1 (fi)
PT (1)	PT783585E (fi)
WO (1)	WO1996010088A1 (fi)
ZA (1)	ZA958128B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2161095A1 (en) *	1993-04-20	1994-10-27	Solis Therapeutics, Inc.	Methods and materials for treatment of individuals infected with intracellular infectious agents
AU709498B2 (en) *	1994-12-12	1999-09-02	Genetic Therapy, Inc.	Improved adenoviral vectors and producer cells
AUPN477695A0 (en) *	1995-08-14	1995-09-07	Commonwealth Scientific And Industrial Research Organisation	Gene therapy
FR2753379B1 (fr)	1996-09-13	1998-10-30	Rhone Poulenc Rorer Sa	Methode de traitement de la sclerose laterale amyotrophique
GB9711957D0 (en) *	1997-06-09	1997-08-06	Isis Innovation	Methods and reagents for vaccination
AU1288099A (en)	1997-10-30	1999-05-24	Cornell Research Foundation Inc.	A method of inhibiting an immune response to a recombinant vector
JP2002528056A (ja)	1998-08-28	2002-09-03	デューク・ユニバーシティー	ＩＶａ２、１００Ｋ及び／又は末端前タンパク質配列における欠失型アデノウイルス
FR2794771B1 (fr)	1999-06-11	2001-08-10	Aventis Pharma Sa	Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
FR2799472B1 (fr)	1999-10-07	2004-07-16	Aventis Pharma Sa	Preparation d'adenovirus recombinants et de banques adenovirales
AUPR518501A0 (en)	2001-05-22	2001-06-14	Unisearch Limited	Yin yang-1
US20040106194A1 (en) *	2002-08-22	2004-06-03	Bett Andrew J.	Methods for propagating adenovirus and virus produced thereby
SI2002003T1 (sl)	2005-05-27	2016-05-31	Ospedale San Raffaele S.R.L.	Genski vektor, ki vsebuje mi-RNA

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5585362A (en) *	1989-08-22	1996-12-17	The Regents Of The University Of Michigan	Adenovirus vectors for gene therapy
FR2707664B1 (fr) *	1993-07-13	1995-09-29	Centre Nat Rech Scient	Vecteurs viraux et utilisation en thérapie génique.

1994
- 1994-09-27 FR FR9411511A patent/FR2724945B1/fr not_active Expired - Fee Related
1995
- 1995-09-22 WO PCT/FR1995/001228 patent/WO1996010088A1/fr not_active Ceased
- 1995-09-22 JP JP8511437A patent/JPH10506018A/ja not_active Ceased
- 1995-09-22 ES ES95932050T patent/ES2268695T3/es not_active Expired - Lifetime
- 1995-09-22 PT PT95932050T patent/PT783585E/pt unknown
- 1995-09-22 AT AT95932050T patent/ATE331801T1/de not_active IP Right Cessation
- 1995-09-22 EP EP95932050A patent/EP0783585B1/fr not_active Expired - Lifetime
- 1995-09-22 FI FI971275A patent/FI971275A0/fi unknown
- 1995-09-22 DK DK95932050T patent/DK0783585T3/da active
- 1995-09-22 MX MX9701766A patent/MX9701766A/es not_active IP Right Cessation
- 1995-09-22 US US08/809,476 patent/US6200798B1/en not_active Expired - Fee Related
- 1995-09-22 AU AU35250/95A patent/AU712304B2/en not_active Ceased
- 1995-09-22 CA CA002197904A patent/CA2197904A1/fr not_active Abandoned
- 1995-09-22 KR KR1019970701945A patent/KR100484441B1/ko not_active Expired - Fee Related
- 1995-09-22 DE DE69535093T patent/DE69535093T2/de not_active Expired - Fee Related
- 1995-09-27 ZA ZA958128A patent/ZA958128B/xx unknown
- 1995-09-27 IL IL115432A patent/IL115432A/en not_active IP Right Cessation
1997
- 1997-03-18 NO NO19971247A patent/NO319055B1/no unknown

Also Published As

Publication number	Publication date
ATE331801T1 (de)	2006-07-15
EP0783585B1 (fr)	2006-06-28
DE69535093D1 (de)	2006-08-10
US6200798B1 (en)	2001-03-13
CA2197904A1 (fr)	1996-04-04
WO1996010088A1 (fr)	1996-04-04
NO971247D0 (no)	1997-03-18
IL115432A (en)	2006-10-05
EP0783585A1 (fr)	1997-07-16
NO319055B1 (no)	2005-06-13
FI971275A7 (fi)	1997-03-26
JPH10506018A (ja)	1998-06-16
KR970706397A (ko)	1997-11-03
DK0783585T3 (da)	2006-10-23
DE69535093T2 (de)	2007-01-04
FI971275L (fi)	1997-03-26
AU712304B2 (en)	1999-11-04
MX9701766A (es)	1997-06-28
NO971247L (no)	1997-03-18
ES2268695T3 (es)	2007-03-16
FR2724945A1 (fr)	1996-03-29
IL115432A0 (en)	1996-01-31
AU3525095A (en)	1996-04-19
PT783585E (pt)	2006-11-30
KR100484441B1 (ko)	2006-01-27
ZA958128B (en)	1996-04-24
FR2724945B1 (fr)	1996-12-27

Publication	Publication Date	Title
FI951138A7 (fi)	1995-04-13	Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
FI971613A7 (fi)	1997-04-16	Defektiivisiä adenoviruksia, jotka käsittävät terapeuttisen geenin ja immunoprotektiivisen geenin
KR970706806A (ko)	1997-12-01	신규한 아데노바이러스성 벡터, 패키징 세포주, 재조합 아데노바이러스와 그 방법(novel adenoviral vectors, packagning cell lines, recombinant adenoviruses and methods)
FR2712603B1 (fr)	1996-02-09	Virus recombinants, préparation et utilisation en thérapie génique.
ATE313640T1 (de)	2006-01-15	Adenovirales fiberprotein mit einem kurzen schaft und seine verwendung
FI971275A0 (fi)	1997-03-26	Inaktivoidun IVa2-geenin käsittävät epätäydelliset yhdistelmä-DNA-tekniset adenovirukset
MX9702553A (es)	1997-06-28	Adenovirus libres de particulas contaminantes viables, su preparacion y su uso.
HUP9802217A3 (en)	1999-09-28	Recombinant mva virus, and the use thereof
PL361307A1 (en)	2004-10-04	Casein derived peptides and uses thereof in therapy
FR2718150B1 (fr)	1996-04-26	Virus recombinants, préparation et utilisation en thérapie génique.
FI973309A0 (fi)	1997-08-12	Menetelmä yhdistelmä-DNA-adenovirusgenomin valmistamiseksi
FR2712602B1 (fr)	1996-02-09	Virus recombinants, préparation et utilisation en thérapie génique.
MX9702078A (es)	1997-06-28	Adenovirus que comprenden dos genes terapeuticos: suicida e inmunoestimulante.
FR2717495B1 (fr)	1996-04-12	Virus recombinants, préparation et utilisation en thérapie génique.
FR2717496B1 (fr)	1996-04-12	Virus recombinants, préparation et utilisation en thérapie génique.
CA2475337A1 (en)	1998-08-06	Methods for cultivating cells and propagating viruses
FR2717823B1 (fr)	1996-04-26	Virus recombinants, préparation et utilisation en thérapie génique.
FR2717497B1 (fr)	1996-04-12	Virus recombinants, préparation et utilisation en thérapie génique.
GB9604714D0 (en)	1996-05-01	Recombinant bovine adenovirus vector system and its application in gene therapy and in the development of recombinant vaccine